RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cardiol Therapeutics Stock

Cardiol Therapeutics ROCE 2025

Cardiol Therapeutics ROCE

-1.05

Ticker

CRDL.TO

ISIN

CA14161Y2006

WKN

A2PA9E

In 2025, Cardiol Therapeutics's return on capital employed (ROCE) was -1.05, a 33.15% increase from the -0.79 ROCE in the previous year.

Cardiol Therapeutics Aktienanalyse

What does Cardiol Therapeutics do?

Cardiol Therapeutics Inc is an international biopharmaceutical company specializing in the development of innovative therapies for the treatment of heart diseases. The company was founded in 2006 in Canada and has since built a broad portfolio of products and technologies to improve the treatment of heart diseases. The company's business model is based on research and development of innovative therapies that aim to provide patients with more effective treatments for heart diseases. They collaborate closely with renowned research institutions and clinics worldwide to develop a wide range of innovative treatment options. The company has also specialized in the study of cannabinoids for the treatment of heart diseases, focusing on the development of medications tailored to the needs of patients with heart diseases. They have developed CardiolRx, a patented technology based on cannabinoids, which has shown promising results in clinical studies for the treatment of severe heart diseases such as heart failure and myocarditis. Overall, Cardiol Therapeutics Inc is a biopharmaceutical company dedicated to developing therapies for the treatment of heart diseases, with a focus on collaboration, innovative products, and the potential to significantly improve patient care. Cardiol Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Cardiol Therapeutics's Return on Capital Employed (ROCE)

Cardiol Therapeutics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Cardiol Therapeutics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Cardiol Therapeutics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Cardiol Therapeutics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Cardiol Therapeutics stock

What is the ROCE (Return on Capital Employed) of Cardiol Therapeutics this year?

The ROCE of Cardiol Therapeutics is -1.05 undefined this year.

How has the ROCE (Return on Capital Employed) of Cardiol Therapeutics developed compared to the previous year?

The ROCE of Cardiol Therapeutics has increased by 33.15% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Cardiol Therapeutics?

A high Return on Capital Employed (ROCE) indicates that Cardiol Therapeutics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Cardiol Therapeutics?

A low ROCE (Return on Capital Employed) can indicate that Cardiol Therapeutics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Cardiol Therapeutics impact the company?

An increase in the ROCE of Cardiol Therapeutics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Cardiol Therapeutics affect the company?

A decrease in ROCE of Cardiol Therapeutics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Cardiol Therapeutics?

Some factors that can affect Cardiol Therapeutics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Cardiol Therapeutics so important for investors?

The ROCE of Cardiol Therapeutics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Cardiol Therapeutics take to improve the ROCE?

To improve the ROCE, Cardiol Therapeutics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Cardiol Therapeutics pay?

Over the past 12 months, Cardiol Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cardiol Therapeutics is expected to pay a dividend of 0 CAD.

What is the dividend yield of Cardiol Therapeutics?

The current dividend yield of Cardiol Therapeutics is .

When does Cardiol Therapeutics pay dividends?

Cardiol Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cardiol Therapeutics?

Cardiol Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Cardiol Therapeutics?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cardiol Therapeutics located?

Cardiol Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cardiol Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cardiol Therapeutics from 5/22/2025 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 5/22/2025.

When did Cardiol Therapeutics pay the last dividend?

The last dividend was paid out on 5/22/2025.

What was the dividend of Cardiol Therapeutics in the year 2024?

In the year 2024, Cardiol Therapeutics distributed 0 CAD as dividends.

In which currency does Cardiol Therapeutics pay out the dividend?

The dividends of Cardiol Therapeutics are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cardiol Therapeutics

Our stock analysis for Cardiol Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cardiol Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.